CAMP — CAMP4 Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $233.12m
- $123.60m
- $3.50m
Annual cashflow statement for CAMP4 Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -44.2 | -49.3 | -51.8 | -80.4 |
| Depreciation | ||||
| Non-Cash Items | 3.07 | 4.73 | 5.86 | 36.2 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 1.7 | -1.27 | -1.33 | 13 |
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -38.5 | -44.2 | -45.6 | -29.6 |
| Capital Expenditures | -4.03 | -0.678 | -0.441 | -0.279 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | — | — | — | 0.036 |
| Sale of Fixed Assets | ||||
| Cash from Investing Activities | -4.03 | -0.678 | -0.441 | -0.243 |
| Financing Cash Flow Items | 0 | 0.438 | -4.44 | 14.8 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 100 | 0.301 | 71.7 | 75.9 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 57.6 | -44.5 | 25.7 | 46.1 |